On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo Bayer ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception. The industry is grappling with significant market shifts amidst emerging ...

Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its ...

IPC Indice de Precios Y Cotizaciones 52,672.42-428.41-0.81% ...

After hours: March 21 at 7:33:25 PM EDT Loading Chart for TERN ...

After hours: March 21 at 7:59:58 PM EDT Loading Chart for TNXP ...

Biopharmaceutical company developing drugs for neurological disorders.

**NM signifies a non meaningful value. A dash signifies the data is not available.